Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules

Fig. 4

Comparison of Percepta GSC score variability. The inter-class score SD includes biological variation between cancer and benign samples and was computed from samples in the Percepta GSC validation set. The dashed line denotes the SD of 0.334, which was determined by flip-rate analysis to be the minimum SD at which performance of Percepta GSC was severely affected

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us